When a sponsor approached Worldwide with a Phase III study for an ultra-rare kidney disease, C3 glomerulonephritis (C3GN), we anticipated several challenges, such as intricate logistics, strict entry criteria, and multiple kidney biopsies that increased burden on the patients. Despite these challenges, Worldwide implemented a strategic support system that coordinated in-person meetings, provided home health services, enhanced physician-patient relationships, and more.
Want to discover what other solutions we utilized that allowed us to complete enrollment at 130% of target? Read our case study to find out.
Supporting Sites and Subjects in Phase III Rare Kidney Disease Study
Read more